Defining a Therapeutic Ratio for Stereotactic Ablative Radiation Therapy in Oligometastatic Disease-Another Piece of the Puzzle
JAMA Oncol
.
2022 Nov 1;8(11):1650-1651.
doi: 10.1001/jamaoncol.2022.4342.
Authors
Matthew S Katz
1
,
Gregory A Russo
2
Affiliations
1
Department of Radiation Medicine, Lowell General Hospital, Lowell, Massachusetts.
2
Section of Radiation Oncology, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
PMID:
36173641
DOI:
10.1001/jamaoncol.2022.4342
No abstract available
Publication types
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung* / pathology
Humans
Lung Neoplasms* / pathology
Radiosurgery*